List of Cirdan Ultra LIS Customers
Lisburn, BT27 5SR,
United Kingdom
Since 2010, our global team of researchers has been studying Cirdan Ultra LIS customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased Cirdan Ultra LIS for Laboratory Management from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using Cirdan Ultra LIS for Laboratory Management include: National Blood Authority Australia, a Australia based Government organisation with 97 employees and revenues of $1.21 billion, Sherwood Forest Hospitals United Kingdom, a United Kingdom based Healthcare organisation with 5849 employees and revenues of $597.0 million, Australian Clinical Labs, a Australia based Healthcare organisation with 4900 employees and revenues of $446.0 million, Australian Centre for the Prevention of Cervical Cancer, a Australia based Non Profit organisation with 200 employees and revenues of $20.0 million and many others.
Contact us if you need a completed and verified list of companies using Cirdan Ultra LIS, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The Cirdan Ultra LIS customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight | Insight Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Australian Centre for the Prevention of Cervical Cancer | Non Profit | 200 | $20M | Australia | Cirdan Imaging | Cirdan Ultra LIS | Laboratory Management | 2024 | n/a | In 2024 the Australian Centre for the Prevention of Cervical Cancer implemented Cirdan Ultra LIS from Cirdan Imaging to modernise its pathology division VCS Pathology. The deployment, announced by Cirdan in May 2024, targeted centralised Laboratory Management for HPV and cervical screening workflows across ACPCC. Cirdan Ultra LIS was configured to deliver core laboratory management capabilities including sample accessioning and tracking, structured data management, quality control workflows and consolidated reporting orchestration. Configuration emphasized workflow automation, role based access controls and standardized laboratory procedures to support pathology operations and quality assurance activities. Operational scope covered ACPCC's pathology division and VCS Pathology sites and extended support for cervical cancer prevention workflows in Australia and the Indo Pacific. The implementation established a centralised digital environment to streamline sample and data flows and to consolidate quality control and reporting processes for HPV screening. Rollout and governance were executed throughout 2024 with phased adoption across the pathology division, aligning laboratory procedures to the new system and formalizing standard operating workflows for screening and reporting. The program focused on consolidating data governance and operational workflows within the Cirdan Ultra LIS deployment rather than on external integration specifics. | |
 |
Australian Clinical Labs | Healthcare | 4900 | $446M | Australia | Cirdan Imaging | Cirdan Ultra LIS | Laboratory Management | 2018 | n/a | In 2018, Australian Clinical Labs implemented Cirdan Ultra LIS as part of a program to operate a single national Laboratory Management system. The deployment focused on South Western Victoria, with Portland and Warrnambool going live on 1 September 2018, and Geelong and Colac going live on 17 November 2018, consolidating regional laboratories onto the Cirdan Ultra LIS platform. Cirdan Ultra LIS was configured to deliver core Laboratory Management functionality, including specimen accessioning, electronic test ordering, results management and reporting, patient demographic and history access, and configurable pathology sign‑out workflows. The implementation emphasized workflow configuration to support local pathology practice and to enable remote specialist review and sign‑off by the national pathology network. Operationally the project completed Australian Clinical Labs’ national program to replace LabTrak, with LabTrak preserved as an archived system for patient history reference from the listed cutover dates. The move to Cirdan Ultra LIS centralized laboratory information management across the company’s sites in Victoria’s South West, and it was positioned to improve access to the expertise of over 95 specialist pathologists across Australia. Governance and rollout were executed on a staged weekend cutover schedule to minimize impact on referrers and patients, and Clinical Labs produced a companion booklet for referrers and practice managers to support the change. The deployment standardized Laboratory Management processes across the region, archived prior patient histories in LabTrak for reference, and explicitly enabled broader specialist pathology collaboration across the national estate. | |
 |
National Blood Authority Australia | Government | 97 | $1.2B | Australia | Cirdan Imaging | Cirdan Ultra LIS | Laboratory Management | 2015 | n/a | In 2015 National Blood Authority Australia implemented Cirdan Ultra LIS. The project was announced in December 2015 as the first comprehensive Laboratory Management system to fully interface with Australia’s BloodNet, explicitly targeting transfusion and blood-supply workflows. Cirdan Ultra LIS provided laboratory management capabilities focused on blood inventory and transfusion management, delivering real-time data exchange to participating sites and reducing manual data entry. The Cirdan Ultra LIS deployment centralized electronic exchange of inventory and transfusion records, improving data quality for blood stock and patient transfusion events. The implementation established a direct integration between Cirdan Ultra LIS and Australia’s BloodNet, enabling synchronous updates across participating laboratories in Australia. The integration announcement occurred in December 2015 and rollout across sites completed in the months following the announcement, covering transfusion services and blood bank operations. Governance adjustments emphasized standardized transfusion workflows and data exchange protocols across sites to support consistent inventory reporting and patient safety processes. Outcomes reported with the Cirdan Ultra LIS integration included reduced manual data entry and improved data quality for blood inventory and transfusion management. | |
 |
|
Healthcare | 5849 | $597M | United Kingdom | Cirdan Imaging | Cirdan Ultra LIS | Laboratory Management | 2024 | n/a |
|
|
Buyer Intent: Companies Evaluating Cirdan Ultra LIS
- NHS, a United Kingdom based Healthcare organization with 1297455 Employees
- Nuffield Health, a United Kingdom based Healthcare company with 16400 Employees
- Mater Health, a Australia based Non Profit organization with 10000 Employees
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||